期刊文献+

甲下黑素瘤一例

Subungual melanoma:a case report
下载PDF
导出
摘要 患者,男,58岁。右足拇趾趾甲色黑7年余,病理确诊为甲下黑素瘤。经系统检查后未发现淋巴结转移,于肿瘤医院行远节拇趾截趾术,术后仍在随访中。 A 58-year-old male presented with black nail on the right hallex for more than 7 years,and the pathological features was accordance with the diagnosis of subungual melanoma.Systematic examination showed that no lymph node was involved.Distal thumb amputation was performed.The patient is under follow-up.
作者 王晶 马国章 柳曦光 WANG Jing;MA Guozhang;LIU Xiguang(Heilongjiang University of Chinese Medicine,Harbin 150036,China;Heilongjiang Provincial Hospital Dermatology Hospital,Harbin 150036,China)
出处 《中国麻风皮肤病杂志》 2020年第7期417-419,共3页 China Journal of Leprosy and Skin Diseases
关键词 甲下黑素瘤 subungual melanoma
  • 相关文献

参考文献2

二级参考文献20

  • 1Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guide- line. Eur J Cancer, 2010, 46(2): 270-283.
  • 2Coit DG, Andtbacka R, Biehakjian CK, et al. Melanoma. J Natl Compr Cane Netw, 2009, 7(3): 250-275.
  • 3Lane JE, Dalton RR, Sangueza OP. Cutaneous melanoma: detecting it earlier, weighing management options. J Fam Pract, 2007, 56( 1 ): 18-28.
  • 4Yoniek DV, Ballo RM, Kahn E, et al. Predictors of positive sentinel lymph node in thin melanoma. Am J Surg, 2011, (3): 324-328.
  • 5Yi JH, Yi SY, Lee HR, et al. Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia. Melanoma Res, 2011, 21(3): 223-227.
  • 6Pejcic I, Vrbic S, Filipovic S, et al. Concurrent chemoim- munotherapy: is it still the best option for the treatment of metastatic melanoma in patients with good performance status? J BUON, 2010, 15(3): 470-474.
  • 7Wierzbicka-Hainaut E, Sassolas B, Mourey L, et al. Temozolo- mide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial. Melanoma Res, 2010, 20(2): 141-146.
  • 8Kottschade LA, Suman V J, Amatruda T 3rd, et al. A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treat- ment Group Study, N057E (1). Cancer, 2011, 117 (8): 1704- 1710.
  • 9Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med, 2006, 354(7): 709-718.
  • 10Hansson J, Aamdal S, Bastholt L, et al. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a ran- domised vhase 3 trial. Lancet Oncol, 2011, 12(2): 144-152.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部